Loading…
Based on limited metadata from the April 2020 FDA Warning Letter, Hopewell Essential Oils received enforcement action for products classified as drugs rather than cosmetics or dietary supplements. Without access to the full letter text or detailed subject line, the specific violations cannot be determined, though the drug classification suggests potential issues with unsubstantiated therapeutic claims or manufacturing/labeling deficiencies. The letter was issued by the FDA's drug regulatory division, indicating the agency determined the company's essential oil products met the legal definition of drugs and were subject to pharmaceutical compliance requirements.